Sisomicin: Evaluation In Vitro and Comparison with Gentamicin and Tobramycin

Author:

Crowe Christine C.12,Sanders Eugene12

Affiliation:

1. Department of Immunology-Medical Microbiology, University of Florida College of Medicine, Gainesville, Florida 32601

2. Department of Medicine, University of Florida College of Medicine, Gainesville, Florida 32601

Abstract

Sisomicin is a new antibiotic produced by Micromonospora inyoensis . The in vitro activities of sisomicin, gentamicin, and tobramycin, three similar aminoglycosides, were determined against 228 clinical isolates representing 10 genera of common pathogens. No difference was noted in the activities of these antimicrobial agents when assayed by a standard broth dilution technique against Klebsiella, Enterobacter, Escherichia, Salmonella, Citrobacter , enterococci, or Staphylococcus aureus . Sisomicin was significantly more active than tobramycin against Serratia and indole-positive Proteus strains. Sisomicin was significantly more active than gentamicin against indole-negative Proteus strains and slightly more active against indole-positive Proteus strains. Tobramycin was more active than sisomicin or gentamicin against Pseudomonas and indole-negative Proteus strains. Gram-negative bacilli resistant to one of the three antimicrobial agents were not necessarily resistant to either of the other two. Activity of sisomicin was independent of the susceptibility or resistance of these isolates to nine other antimicrobial agents as assayed by the Bauer-Kirby technique. The presence of 50% human serum did not antagonize the in vitro activity of sisomicin against gram-negative isolates. Because sisomicin showed certain advantages over gentamicin or tobramycin in vitro, further investigation of this new antimicrobial agent is warranted.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Reference12 articles.

1. Numerical diagnostic key for the identification of;Baer H.;Enterobacteriaceae. Appl. Microbiol.,1972

2. Antibiotic susceptibility testing by a standardized single disc method;Bauer A. W.;Amer. J. Clin. Pathol.,1966

3. Preliminary studies with nebramycin factor 6;Black H. R.;Antimicrob. Ag. Chemother.,1971

4. Cross-resistance of Pseudomonas to gentamicin and tobramycin;Brusch J. L.;Antimicrob. Ag. Chemother.,1972

5. Is there complete cross-resistance of gram-negative bacilli to gentamicin and tobramycin;Crowe C. C.;Antimicrob. Ag. Chemother.,1972

Cited by 69 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3